Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 309

1.

In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells.

Asadishad B, Vossoughi M, Alamzadeh I.

Biotechnol Lett. 2010 May;32(5):649-54. doi: 10.1007/s10529-010-0208-x. Epub 2010 Feb 4.

PMID:
20131082
[PubMed - indexed for MEDLINE]
2.

Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.

Shen Z, Li Y, Kohama K, Oneill B, Bi J.

Pharmacol Res. 2011 Jan;63(1):51-8. doi: 10.1016/j.phrs.2010.10.012. Epub 2010 Oct 28.

PMID:
21035550
[PubMed - indexed for MEDLINE]
3.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
[PubMed - indexed for MEDLINE]
4.

Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.

Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.

Biomaterials. 2009 Oct;30(30):6065-75. doi: 10.1016/j.biomaterials.2009.07.048. Epub 2009 Aug 12.

PMID:
19674777
[PubMed - indexed for MEDLINE]
5.

Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.

Yoo HS, Park TG.

J Control Release. 2004 Nov 24;100(2):247-56.

PMID:
15544872
[PubMed - indexed for MEDLINE]
6.

Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.

Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.

Eur J Pharm Biopharm. 2010 Sep;76(1):10-6. doi: 10.1016/j.ejpb.2010.05.005. Epub 2010 May 22.

PMID:
20472060
[PubMed - indexed for MEDLINE]
7.

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.

Misra R, Sahoo SK.

Eur J Pharm Sci. 2010 Jan 31;39(1-3):152-63. doi: 10.1016/j.ejps.2009.11.010. Epub 2009 Dec 2.

PMID:
19961929
[PubMed - indexed for MEDLINE]
8.

Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.

Azarmi S, Tao X, Chen H, Wang Z, Finlay WH, Löbenberg R, Roa WH.

Int J Pharm. 2006 Aug 17;319(1-2):155-61. Epub 2006 Apr 18.

PMID:
16713150
[PubMed - indexed for MEDLINE]
9.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
[PubMed - indexed for MEDLINE]
10.

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.

Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.

Biomaterials. 2010 Jul;31(21):5634-42. doi: 10.1016/j.biomaterials.2010.03.066. Epub 2010 Apr 28.

PMID:
20430433
[PubMed - indexed for MEDLINE]
11.

Targeted magnetic liposomes loaded with doxorubicin.

Pradhan P, Banerjee R, Bahadur D, Koch C, Mykhaylyk O, Plank C.

Methods Mol Biol. 2010;605:279-93. doi: 10.1007/978-1-60327-360-2_19.

PMID:
20072888
[PubMed - indexed for MEDLINE]
12.

Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.

Guo M, Que C, Wang C, Liu X, Yan H, Liu K.

Biomaterials. 2011 Jan;32(1):185-94. doi: 10.1016/j.biomaterials.2010.09.077. Epub 2010 Nov 9.

PMID:
21067808
[PubMed - indexed for MEDLINE]
13.

Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.

Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY.

Biomaterials. 2007 Mar;28(7):1423-33. Epub 2006 Dec 1.

PMID:
17141308
[PubMed - indexed for MEDLINE]
14.

Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.

Clin Cancer Res. 2000 May;6(5):1949-57.

PMID:
10815920
[PubMed - indexed for MEDLINE]
Free Article
15.

Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.

Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X.

Biomed Microdevices. 2008 Oct;10(5):693-700. doi: 10.1007/s10544-008-9180-9.

PMID:
18350380
[PubMed - indexed for MEDLINE]
16.

Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.

Pan XQ, Wang H, Lee RJ.

Pharm Res. 2003 Mar;20(3):417-22.

PMID:
12669962
[PubMed - indexed for MEDLINE]
17.

Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.

Nan A, Ghandehari H, Hebert C, Siavash H, Nikitakis N, Reynolds M, Sauk JJ.

J Drug Target. 2005 Apr;13(3):189-97.

PMID:
16036307
[PubMed - indexed for MEDLINE]
18.

[Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].

Zhang LK, Hou SX, Mao SJ, Wei DP, Song XR.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jan;37(1):77-9. Chinese.

PMID:
16468648
[PubMed - indexed for MEDLINE]
19.

Folate conjugated doxorubicin-loaded membrane vesicles for improved cancer therapy.

Mishra PR, Jain NK.

Drug Deliv. 2003 Oct-Dec;10(4):277-82.

PMID:
14612344
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk